Pennystocksupdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 08/29/2013 -- China Ming Yang Wind Power Group Limited (NYSE:MY) reported that its second-quarter loss to shareholders widened to RMB 62.95 million or RMB 0.51 per share, from a loss of RMB 30.15 million or RMB 0.25 per share, a year ago. Total revenue was RMB 537.4 million, a decrease of 32.7% compared to RMB 798.0 million prior year.
The gross margin was 12.29%, compared to 14.52% the prior year. The company said the decrease was primarily due to a decrease in the ASP of WTGs commissioned during the second quarter of 2013 which outpaced the decrease in cost of sales.
Click here to receive FREE breaking news email alerts for China Ming Yang Wind Power Group Ltd.
Cimatron Ltd.(NASDAQ:CIMT) stocks dropped 7.12% to $6.13. The company on Aug 13 declared financial outcomes for the second one fourth and first six several weeks in 2013. Earnings for the second one fourth of 2013 were $11.0 thousand, in comparison to $10.6 thousand documented in the second one fourth of 2012. Net Benefit for the second one fourth of 2013 was $1.0 thousand, or $0.11 per watered down discuss, in comparison to a net gain of $1.0 thousand, or $0.11 per watering down discuss, documented in the same one fourth of 2012.
For the first six several weeks of 2013, revenues were $21.2 thousand, in comparison to $20.5 thousand in the same period of 2012. In the first six several weeks of 2013, net gain was $1.6 thousand, or $0.17 per watered down discuss, in comparison to a net gain of $1.8 thousand, or $0.20 per watered down discuss, in the first six several weeks of 2012.
How Should Traders Business CIMT After The Latest Volatility? Get Free Pattern Research Here.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) started its dialing period with the price of $6.80 and shot in $6.69 by reviewing -1.62%. ARNA’s shares exchanged with total volume of 3.44 thousand shares, while the average dealing stayed 4.24 thousand shares. Arena Pharmaceuticals, Inc a biopharmaceutical company, involves in finding, creating, and commercializing novel drugs that target G protein-coupled receptors in the healing areas of heart, neurological system, information related, and metabolic illnesses.
Is ARNA All Set To Bounce Back From New Low And Hit $15? Get Special Report Here.
Vodafone Group PLC (Nasdaq:VOD) is +2.314 - +7.87% for the past near of $29.41. It exchanged between $31.43 - 32.00 with complete exchanged numbers of 46655764 stocks. Keep an eye on VOD, as the stock has been displaying uncommon goes over the past several weeks. At Rate, VOD has retrieved +29.91% from its 52-week Low of 24.42 and has Retracted +2.27% from its 52-week high of 31.02.
Click here to receive FREE breaking news email alerts for VOD.
Neither Pennystocksupdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by Pennystocksupdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.Pennystocksupdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Pennystocksupdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)